Introduction to Diagnostic Microbiology Flashcards

2
Q

How differentiate Staphyloccocus aureus from other Staphylococcus species?

A
  • -* coagulase positive, other species are coagulase negative
  • beta-hemolytic, other species are non-hemolytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does catalase do?

A
  • prevents bacteria oxidative damage by reactive oxygen species, by catalysing H2O2 to water and oxygen
  • all Staphyloccus species are catalase-positive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does coagulase do?

A
  • leads to fibrin formation around bacteria, protecting it from phagocytosis
  • found within Staphylococcus aureus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where is Staphylococci found?

A
  • ubiquitous (found everywhere)
  • Coagulase-negative staphylocci are part of skin normal flora

: ~30% of normal healthy adults are persistant nasopharyngeal carriers of S. aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is Staphylococci spread?

A
  • person-to-person spread through direct contact or exposure to contaminated fomites (e.g. bed linens, clothing, etc.)
  • among the most common causes of community and/or hospital acquired infections

(some strains are resistant to different antibiotics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you differentiate Staphylococcus epidermidis from Staphylococcus aureus?

A
  • S. epidermidis is coagulase-negative
  • considered less virulent than S. aureus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where is S. epidermidis usually associated with and what is its pathogenesis associated with?

A
  • most commonly found associated with prosthetic devices
  • pathogenesis associated with slime layer and biofilm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What causes hemolytic patterns?

A
  • bacteria secrete proteins / metabolites that lyse red blood cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the different hemolytic patterns and their characteristics?

A

alpha: incomplete lysis; green

beta: complete lysis; clear

gamma: no lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mannitol-salt agar

A
  • contains mannitol sugar and pH indicator (phenol red)
  • if an organism can ferment mannitol, an acidic byproduct is formed that will cause the pheno red in the agar to turn yellow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which is (are) the catalse-negative species?

a) enterococci
b) staphylococci
c) streptococci
d) micrococci

A
  • a) enterococci
  • c) streptococci
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Description of Streptococcus

A
  • gram-positive cocci in chains
  • catalase-negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What classifications can be used for Streptococcus?

A

1) Lancefield grouping

: based on cell wall carbohydrate antigens

  • Group A-W (Strep test RAPID)
    2) Hemolytic pattern
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can you differentiate the following in a lab:

  • S. pyogenes*
  • S. pneumoniae*
  • S. agalactiae*

Viridans streptococcus

A

1) hemolytic pattern

  • S. pneumoniae & Viridans strep are alpha-hemolytic
  • S. pyogenes & S. agalactiae are beta-hemolytic

2) Optochin test & capsule presence

  • S. pneumoniae is optochin sensitive & has a capsule
  • Viridans strep is optochin resistant & does not have a capsule

3) Bacitracin test

  • S. pyogenes is bacitracin sensitive
  • S. agalactiae is bacitracin resistant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

S. agalactiae

: Group?

: virulence factors?

: epidemiology?

: transmission?

A
  • Group B streptococcus
  • virulence factors: polysaccharide capsule
  • epidemiology: colonise lower GIT & UGT

: commonly associated with infections of newborns (Meningitis, pneumonia)

  • transmission: increased risk if mother is vaginally colonised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Viridins streptococci

A
  • heterogenous collection of alpha-hemolytic and non-hemolytic streptococci
  • colonises the oropharynx, GIT and UGT
  • avirulent

: can cause dental carries (S. mutans)

: common cause of subacute endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Differentiation of S. pneumoniae and Viridans streps

A

optochin test

S. pneumoniae: sensitive

Viridans streps**: resistant

bile solubility test

S. pneumoniae: sensitive

Viridans streps**: resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Biology of Bacillus anthracis

A
  • gram-positive rods; single or paired
  • aerobic
  • spore-forming
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Virulence factors of B. anthracis

A
  • polypeptide capsule

: consists of poly-D-glutamic acid

  • toxins

: Protecting Antigen (PA)

: Lethal factor (LF)

: Edema factor (EF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Epidemiology & Transmission of B. anthracis

  • reservoir
  • transmission
A

reservoir

  • animals, skins, soil
  • human infections via exposure to reservoirs

transmission

  • innoculation (most common form of transmission)
  • ingestion
  • inhalation (i.e. Wool sorter’s disease)

potential for bioterrorism- anthrax

22
Q

Diseases caused by B. anthracis

: cutaneous anthrax

A
  • painless swelling
  • progresses to ulcer surrounded by vesicles
  • necrotic eschar, central, with erythematous border often with painful regional lymphadenopathy
23
Q

Diseases caused by B. anthracis

: gastrointestinal anthrax

A
  • rare
  • symptoms are based on site of infection
  • swelling
  • vomiting, bloody diarrhea
24
Q

Diseases caused by B. anthracis

: pulmonary anthrax

A
  • life-threatening
  • leads to shock if without treatment
  • macrophages ingest bacteria and transport to lymph nodes
  • fever, malaise, swelling, dyspnea
25
Q

Diagnosis of B. anthracis

A
  • gram-stain: gram-positive rods
  • culture: non-hemolytic
  • serology
  • PCR
  • public health reference lab (CDC select agent)
26
Treatment for *B. anthracis*
- Ciprofloxacin - doxycycline - vaccine: toxoid, AVA, high risk only
27
*Bacillus cereus* epidemiology & transmission
- ubiquitous (found in nearly all environments) - transmission: foodbourne : associated with fried rice : food kept warm (not hot) : buffets
28
Pathogenesis & Disease of *B. cereus*
**eye infections** **gastroenteritis** (most severe form) - heat-stable form - heat-labile form
29
Heat-stable form of *B. cereus*
- emetic (vomitting) form associated with enterotoxins : ingestion of enterotoxins, not bacteria : incubation period short (1-6 hours) : illness duration short (~24 hours) : vomitting, nausea, abdominal cramps
30
Heat-labile form of *B. cereus*
- diarrheal form : stimulates adenylate cylate-cAMP system in intestinal epithelial cells : profuse watery diarrhea : true infection with bacteria : contaminated meat and sauces
31
Diagnosis of *B. cereus*
**culture and gram-stain** - clinical specimens - implicated foods
32
Treatment of *B. cereus*
- vancomycin (glycopeptide) - ciprofloxacin (quinolone) - gentamicin (amino glycoside)
33
Biology of *Corynebacterium*
- Gram-positive; irregular, "club-shaped" rods - aerobic - catalase-positive - non-spore forming
34
Virulence factors of *Corynebacterium diphtheriae*
**diphtheria toxin** - lysogenic bacteriophage - beta-phage - introduces exotoxin encoded on tox gene - toxin inhibits protein synthesis by inactivating elongating factor 2 (EF-2)
35
Epidemiology & Transmission of *C. diphtheriae*
- found worldwide - maintained in population by **asymptomatic carriage** in **oropharynx** & **skin** - transmission via **respiratory droplets** - immunisation program in US controls disease
36
Pathogenesis & Disease of *C. diphtheriae*
- respiratory : sudden onset, malaise, sore throat : exudative pharyngitis progresses into **psuedomembrane** (whitish plaque)- bacteria, dead cells, fibrin: firmly adheres to underlying tissue : systemic complications (myocarditis, recurrent laryngeal nerve palsy)
37
Diagnosis of *C. diphtheriae*
**- clinical diagnosis** **- culture:** selective medium- cysteine-tellurite blood agar (CTBA) : tellurite inhibits growth of most URT bacteria and gram-negative rods : reduced by *C. diphtheriae-* produces **gray/black colour** on agar **- PCR:** detect tox gene **- toxigenicity testing:** producing of exotoxin **:** Elk test
38
Diagnosis of *C. diphtheriae* with Elk test
- sterile paper with diphtheria antitoxin imbedded into agar medium - *C. diphtheriae* isolates are streaked across plate ar 90 degrees to the antitoxin strip - toxigenic *C. diphtheriae* is detected because secreted toxin diffuses from area of growth and reacts with antitoxin to form lines of precipitin
39
Prevention & treatment of *C. diphtheriae*
- penicillin or vancomycin - antitoxin - education on vaccination - DPT vaccine (diphtheria, pertussis, tetanus antigens)
40
*Myobacterium* biology
- aerobic rods - cell wall is rich in lipids : mycolic acids- increases resistance to desiccation and many chemicals - acid-fast bacilli
41
*Myobacterium tuberculosis* biology
- facultative intracellular pathogen (can live/reproduce inside/outisde of cell) - aerobic rod
42
virulence factors *M. tuberculosis*
- dormant in macrophages - cord factor : 2 mycolic acids together with a disaccharide (2 molecules of glucose) : inhibits neutrophil migration and damages mitochondria - sulfatides : prevent phagosome fusion with lysosome containing bacterocidal enzymes
43
Epidemiology & transmission of *M. tuberculosis*
- reservoir: human lungs - transmission via respiratory droplets : coughing, sneezing : ventilation & isoloationi important to prevent transmission
44
pathogenesis & disease of *M. tuberculosis*
1. enters airways and penetrates alveoli 2. phagocytosed by alveolar macrophages 3. bacteria multiply (days-weeks) in macrophages 4. infected macrophages travel to regional lymph nodes (hilar, mediastinal) and tissues 5. alveolar macrophages release cytokines (IL-12 and TNF-alpha) that increases local inflammation and recruits T-cells 6. T-cells are activated and secrete IFN-gamma, which activates macrophages to increase phagosome-lysosome fusion and intracellular killing of bacteria (phagosome has bacteria)
45
granuloma of *M. tuberculosis*
- prevents further bacteria spread - necrotic mass surrounded by dense wall of CD4, CD8 and NK cells and macrophages - bacteria can remain dormant in this stage or can be reactivated years later when / if the patient's immunity decreases
46
clinical manifestations of *M. tuberculosis*
- initially, non-specific complaints of malaise, weight loss, cough and night sweats : primary infection with resolution or with progression - reactivation - disseminated (military) tuberculosis - sputum may be scant or bloody and purulent (pus) : cavitary disease with tissue destruction is associated with sputum production with hemoptysis
47
How is clinical diagnosis of *M. tuberculosis* supported
1. **radiographic evidence** of pulmonary disease 2. positive **skin test reactivity** 3. **lab dectection**
48
Lab Diagnostics of *M. tuberculosis*
- Auramine-rhondamine staining bacilli (fluroscent apple green) - Acid fast stain (Ziehl Neelson method) - growth is slow on Lowenstein Jensen medium
49
Acid fast stain for *Mycobacterium*
**Ziehl Neelson Method** - carbolfuschin (primary stain- red colour) - acid fast organisms resist decolourization with acid alcohol - after decolourisation, methyelene blue (secondary stain) is added to organisms to counterstain any material that is not acid fast
50